{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T20:24:22Z","timestamp":1793305462634,"version":"4.5.0"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T00:00:00Z","timestamp":1681862400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/ http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Ten to fifty percent of women with advanced or recurrent ovarian cancer develop malignant bowel obstruction (MBO). We described the management and examined the complications and survival of MBO in primary epithelial tubo-ovarian cancer patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Materials and methods:<\/jats:title>\n            <jats:p>The authors conducted a retrospective monocentric cohort study of tubo-ovarian cancer patients diagnosed with MBO between January 1st, 2011 until August 31st, 2017 at the University Hospitals Leuven, Belgium.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Seventy-three patients with a total of 165 MBO episodes (median 1\/patient; range 1\u201314) were included. The median time interval between cancer diagnosis and first MBO episode was 373 days (range 0\u20131937). The median time interval between MBO episodes was 44 days (range 6\u20132004). Complications were bowel perforation (<jats:italic toggle=\"yes\">n<\/jats:italic>=5; 7%) and bowel ischemia (<jats:italic toggle=\"yes\">n<\/jats:italic>=1; 1%). Conservative treatment was applied in 150 (91%) episodes, including gastrostomy in 4 (2%) episodes and octreotide in 79 (48%) episodes. Surgery was necessary in 15 (9%) episodes. Total parenteral nutrition was administered in 16 (22%) patients. During the study period 62 (85%) patients died (median 167 days since first MBO; range 6\u20132256). A significant difference in survival was found regarding the tumor marker CA 125 at cancer diagnosis, the use of palliative chemotherapy after the first episode of MBO and palliative surgical treatment for MBO in a group of well selected patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Tubo-ovarian cancer patients with MBO have a poor prognosis: 85% of the study population died within a relatively short time interval since the first MBO. In our study population, the majority of patients with MBO were treated conservatively. Both palliative chemotherapy and palliative surgical management are considerable treatment options depending on the individual patient profile.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ms9.0000000000000660","type":"journal-article","created":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T13:35:43Z","timestamp":1682084143000},"page":"1539-1545","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Bowel obstruction in advanced tubo-ovarian cancer: a retrospective cohort study"],"prefix":"10.1097","volume":"85","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4546-4514","authenticated-orcid":false,"given":"Jolien","family":"Jansen","sequence":"first","affiliation":[{"name":"Department of Gynecology and Obstetrics, Division of Gynecological Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2141-8313","authenticated-orcid":false,"given":"Eva","family":"Oldenburger","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy Oncology"},{"name":"Department of Palliative Care, Leuven Cancer Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9939-6380","authenticated-orcid":false,"given":"Jente","family":"Jansen","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, KU Leuven, Belgium, European Union"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Wolthuis","sequence":"additional","affiliation":[{"name":"Department of Abdominal Surgery, University Hospitals Leuven"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5432-1828","authenticated-orcid":false,"given":"Els","family":"Van Nieuwenhuysen","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics, Division of Gynecological Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Neven","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics, Division of Gynecological Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignace","family":"Vergote","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics, Division of Gynecological Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7476-3372","authenticated-orcid":false,"given":"Sileny N.","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics, Division of Gynecological Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,5]]},"reference":[{"key":"R1-20250806","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.critrevonc.2006.03.004","article-title":"Ovarian cancer","volume":"60","author":"Colombo","year":"2006","journal-title":"Crit Rev Oncol Hematol"},{"key":"R2-20250806","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.ygyno.2008.11.019","article-title":"Surgical program building in advanced ovarian cancer: European perspective","volume":"114","author":"Verleye","year":"2009","journal-title":"Gynecol Oncol"},{"key":"R4-20250806","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.suc.2007.12.002","article-title":"Ovarian Cancer","volume":"88","author":"Chobanian","year":"2008","journal-title":"Surg Clin North America"},{"key":"R5-20250806","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ygyno.2006.02.013","article-title":"The effect of total parenteral nutrition on the survival of terminally ill ovarian cancer patients","volume":"103","author":"Brard","year":"2006","journal-title":"Gynecol Oncol"},{"key":"R6-20250806","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ygyno.2011.11.007","article-title":"Outcomes of surgical management of bowel obstruction in relapsed epithelial ovarian cancer (EOC)","volume":"125","author":"Kolomainen","year":"2012","journal-title":"Gynecol Oncol"},{"key":"R7-20250806","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.jpainsymman.2016.05.032","article-title":"Somatostatin analogues compared with placebo and other pharmacologic agents in the management of symptoms of inoperable malignant bowel obstruction: a systematic review","volume":"52","author":"Obita","year":"2016","journal-title":"J Pain Symptom Manage"},{"key":"R8-20250806","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.ejso.2013.10.025","article-title":"Bowel obstruction in recurrent gynecologic malignancies: defining who will benefit from surgical intervention","volume":"40","author":"Perri","year":"2014","journal-title":"Eur J Sur Oncol"},{"key":"R9-20250806","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jpainsymman.2006.06.014","article-title":"Medical treatment for inoperable malignant bowel obstruction: a qualitative systematic review","volume":"33","author":"Mercadante","year":"2007","journal-title":"J Pain Symptom Manage"},{"key":"R10-20250806","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/SPC.0b013e3283436d1b","article-title":"Surgical management of bowel obstruction in gynaecological malignancies","volume":"5","author":"Kolomainen","year":"2011","journal-title":"Curr Opin Support Palliat Care"},{"key":"R11-20250806","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1471-0528.2009.02416.x","article-title":"Impact of bowel obstruction at the time of initial presentation in women with ovarian cancer","volume":"117","author":"Rauh-Hain","year":"2010","journal-title":"BJOG"},{"key":"R12-20250806","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ijsu.2016.02.002","article-title":"Challenges and outcome of surgery for bowel obstruction in women with gynaecologic cancer","volume":"27","author":"Furnes","year":"2016","journal-title":"Int J Sur"},{"key":"R13-20250806","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/IGC.0b013e318198ff4b","article-title":"Bowel obstruction and survival in patients with advanced ovarian cancer: analysis of prognostic variables","volume":"19","author":"Sartori","year":"2009","journal-title":"Int J Gynecol Canc"},{"key":"R14-20250806","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/S0140-6736(13)62146-7","article-title":"Ovarian cancer","volume":"384","author":"Jayson","year":"2014","journal-title":"The Lancet"},{"key":"R15-20250806","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1177\/1049909114566225","article-title":"Malignant bowel obstruction in patients with recurrent ovarian cancer","volume":"33","author":"Tran","year":"2016","journal-title":"Am J Hospice Palliative Med\u00ae"},{"key":"R16-20250806","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ygyno.2012.12.028","article-title":"Bowel obstruction in elderly ovarian cancer patients: a population-based study","volume":"129","author":"Mooney","year":"2013","journal-title":"Gynecol Oncol"},{"key":"R17-20250806","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ehmc.2016.02.005","article-title":"Malignant bowel obstruction in advanced cancer","volume":"5","author":"Koo","year":"2016","journal-title":"Hosp Med Clin"},{"key":"R18-20250806","article-title":"Malignant bowel obstruction in advanced cancer patients: epidemiology, management, and factors influencing spontaneous resolution","volume":"159\u201369","author":"Tuca","year":"2012","journal-title":"Cancer Manag Res"},{"key":"R19-20250806","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.ejca.2008.02.028","article-title":"Management of malignant bowel obstruction","volume":"44","author":"Ripamonti","year":"2008","journal-title":"Eur J Cancer"},{"key":"R20-20250806","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1097\/IGC.0000000000000998","article-title":"Treatment patterns, outcomes, and costs for bowel obstruction in ovarian cancer","volume":"27","author":"Suidan","year":"2017","journal-title":"Int J Gynecol Canc"},{"key":"R21-20250806","doi-asserted-by":"crossref","first-page":"106165","DOI":"10.1016\/j.ijsu.2021.106165","article-title":"STROCSS 2021: strengthening the reporting of cohort, cross-sectional and case-control studies in surgery","volume":"96","author":"Mathew","year":"2021","journal-title":"Int J Surg"},{"key":"R22-20250806","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.jpainsymman.2014.09.013","article-title":"Double-blind, placebo-controlled, randomized trial of octreotide in malignant bowel obstruction","volume":"49","author":"Currow","year":"2015","journal-title":"J Pain Symptom Manage"},{"key":"R23-20250806","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12957-015-0455-3","article-title":"Randomized clinical trial comparing octreotide and scopolamine butylbromide in symptom control of patients with inoperable bowel obstruction due to advanced ovarian cancer","volume":"13","author":"Peng","year":"2015","journal-title":"World J Surg Oncol"},{"key":"R24-20250806","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.critrevonc.2011.12.006","article-title":"Octreotide for malignant bowel obstruction: twenty years after","volume":"83","author":"Mercadante","year":"2012","journal-title":"Crit Rev Oncol Hematol"},{"key":"R25-20250806","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1365-277X.2010.01127.x","article-title":"Parenteral nutrition for patients with advanced ovarian malignancy","volume":"24","author":"Madhok","year":"2011","journal-title":"J Human Nutrit Dietet"},{"key":"R26-20250806","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jpainsymman.2006.11.011","article-title":"Complications at the end of life in ovarian cancer","volume":"34","author":"Herrinton","year":"2007","journal-title":"J Pain Symptom Manage"},{"key":"R27-20250806","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.clnu.2014.09.010","article-title":"A systematic review with meta-analysis of survival, quality of life and cost-effectiveness of home parenteral nutrition in patients with inoperable malignant bowel obstruction","volume":"34","author":"Naghibi","year":"2015","journal-title":"Clin Nut"},{"key":"R28-20250806","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/cam4.587","article-title":"Retrospective analysis of systemic chemotherapy and total parenteral nutrition for the treatment of malignant small bowel obstruction","volume":"5","author":"Chouhan","year":"2016","journal-title":"Cancer Med"},{"key":"R29-20250806","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ygyno.2019.04.681","article-title":"Malignant bowel obstruction due to uterine or ovarian cancer: are there differences in outcome?","volume":"154","author":"Hoppenot","year":"2019","journal-title":"Gynecol Oncol"},{"key":"R30-20250806","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s00404-020-05545-y","article-title":"Palliative treatment for bowel obstruction in ovarian cancer: a meta-analysis","volume":"302","author":"Jin","year":"2020","journal-title":"Arch Gynecol Obstet"},{"key":"R31-20250806","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1136\/ijgc-00009577-200509000-00019","article-title":"Palliative care for intestinal obstruction in recurrent ovarian cancer: a multivariate analysis","volume":"15","author":"Mangili","year":"2005","journal-title":"Int J Gynecol Cancer"},{"key":"R32-20250806","first-page":"3157","article-title":"Palliative care in patients with ovarian cancer and bowel obstruction","volume":"23","author":"Daniele","year":"2015","journal-title":"Supp Care Canc"},{"key":"R33-20250806","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1177\/0269216309346544","article-title":"Room for improvement? A quality-of-life assessment in patients with malignant bowel obstruction","volume":"24","author":"Selby","year":"2010","journal-title":"Palliat Med"},{"key":"R34-20250806","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1097\/IGC.0000000000001049","article-title":"Malignant bowel obstruction in relapsed ovarian cancer with peritoneal carcinomatosis: an occlusive state","volume":"27","author":"Martinez Castro","year":"2017","journal-title":"Int J Gynecol Canc"}],"container-title":["Annals of Medicine &amp; Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MS9.0000000000000660","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T13:30:20Z","timestamp":1754487020000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MS9.0000000000000660"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,19]]},"references-count":33,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/ms9.0000000000000660","relation":{},"ISSN":["2049-0801"],"issn-type":[{"value":"2049-0801","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,19]]},"assertion":[{"value":"2022-11-17","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-04-02","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}